Premier Perspectives The blog for insider insights in clinical development Clinical Research: Phase 1 - Phase 4 6 Data Sources You Should Be Using in Your Site Selection Process By Andrea Ochoa October 1, 2024 Featured Posts Celebrating World Patient Safety Day: An Interview with Leading Diagnostics Expert By Charles Chrisawn September 13, 2024 Understanding the Patient Perspective in Rare Diseases: Asking the Right Questions By Premier Research September 6, 2024 Premier Voices Podcast Conversations with Premier's subject matter experts PREMIER VOICES #15 Enhancing Clinical Trial Accessibility – Bringing Oncology Trials to Patients PREMIER VOICES #13 Early-Phase Oncology – Emerging From the Crisis & Innovating for the Future PREMIER VOICES #12 Direct-to-Patient – Is This the ‘New Normal’ for Clinical Trials? PREMIER VOICES #11 Statistical Considerations in the Wake of COVID-19 PREMIER VOICES #10 COVID-19 Update – How the FDA's Emergency Use Authorization Can Help Develop Therapies Faster Premier Voices #8 Engaging Patients in Clinical Trials w/ Alan Thomas Premier Voices #7 Rare Disease Advocacy & International Ataxia Day w/ Alan Thomas (Ataxia & Me) Premier Voices #6 Operationalizing the New MDR With Janet Kube (Part 2) Premier Voices #5 Operationalizing the New MDR With Janet Kube (Part 1) Premier Voices #4 The Placebo Problem Part 2 With Michael Kuss Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseLife at Premier By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Harnessing the Power of Clinical Data with Post-Market Clinical Follow-Up Activities By Caroline Perez August 27, 2024 Consulting Optimized 505(b)(1) and 505(b)(2) Clinical Pharmacology Programs to Accelerate Drug Development By Jayesh Patel August 12, 2024 Clinical ResearchPhase 1 - Phase 4 Navigating Uncertainty with Confidence: Bringing In Vitro Diagnostics to Market in the EU By Charles Chrisawn August 5, 2024 Clinical ResearchPhase 1 - Phase 4 The New Normal for Laboratory Developed Tests: Recent Changes to FDA Regulation By Charles Chrisawn July 23, 2024 Development Strategy Avoiding 3 Common Pitfalls to Efficient Site Selection By Nicole Stansbury July 16, 2024 Clinical ResearchPhase 1 - Phase 4 FDA’s Diversity Mandate: Transforming Clinical Trials and Drug Development for Better Outcomes for All By Premier Research July 10, 2024 1 2 3 … 60 Next × ALSO OF INTEREST7 Questions About Clinical Evaluations for MDRNostalgia or Shell Shock? Assessing PTSD Is a...Designing Pediatric Analgesic Treatment...